Bumper Offer - Urjas oil Just @ Rs. 1
Olmetime AM 40 Mg/5 Mg Tablet is a prescription drug, available for use as Tablet. Other than this, Olmetime AM 40 Mg/5 Mg Tablet has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Olmetime AM 40 Mg/5 Mg Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Olmetime AM 40 Mg/5 Mg Tablet include Upper respiratory tract infection. Some other side effects of Olmetime AM 40 Mg/5 Mg Tablet have been listed ahead. Normally, these side effects of Olmetime AM 40 Mg/5 Mg Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Olmetime AM 40 Mg/5 Mg Tablet's effect during pregnancy is Severe and Mild while nursing. Warnings related to Olmetime AM 40 Mg/5 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Olmetime AM 40 Mg/5 Mg Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease as it can result in adverse effects. Other conditions have been mentioned below in the Olmetime AM 40 Mg/5 Mg Tablet contraindications section.
Additionally, Olmetime AM 40 Mg/5 Mg Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Olmetime AM 40 Mg/5 Mg Tablet is not safe while driving, and is is not addictive in nature.
Olmetime AM 40 Mg/5 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Olmetime AM 40 Mg/5 Mg Tablet is used -
Moderate
Mild
Is the use of Olmetime AM 40 Mg/5 Mg Tablet safe for pregnant women?
Olmetime AM can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Olmetime AM 40 Mg/5 Mg Tablet safe during breastfeeding?
Side effects of Olmetime AM on breastfeeding women are very mild.
What is the effect of Olmetime AM 40 Mg/5 Mg Tablet on the Kidneys?
Very few cases of side effects of Olmetime AM on kidney have been reported.
What is the effect of Olmetime AM 40 Mg/5 Mg Tablet on the Liver?
Olmetime AM may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Olmetime AM 40 Mg/5 Mg Tablet on the Heart?
Side effects of Olmetime AM rarely affect the heart.
Olmetime AM 40 Mg/5 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmetime AM 40 Mg/5 Mg Tablet unless your doctor advises you to do so -
Is this Olmetime AM 40 Mg/5 Mg Tablet habit forming or addictive?
Olmetime AM 40 Mg/5 Mg Tablet is not addictive in nature.
Interaction between Food and Olmetime AM 40 Mg/5 Mg Tablet
Olmetime AM 40 Mg/5 Mg Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Olmetime AM 40 Mg/5 Mg Tablet
Consult your doctor before consuming alcohol while taking Olmetime AM 40 Mg/5 Mg Tablet as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
